SEC Company Response from Vincerx Pharma, Inc. (VINC) (CIK 0001796129) (VINC) — Mar 5, 2020
Vincerx Pharma, Inc. (VINC) (CIK 0001796129)
Date: March 5, 2020 · CIK: 0001796129 · Accession: 0001104659-20-029523
AI Filing Summary & Sentiment
File numbers found in text: 333-236466
Letter
VIA EDGAR & TELECOPY Division of Corporation Finance Office of Real Estate & Construction Washington, D.C. 20549 RE: LifeSci Acquisition Corp. (the “Company”) Registration Statement on Form S-1 (File No. 333-236466) (the “Registration Statement”)
Dear Mr. Alper:
The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. on March 5, 2020, or as soon thereafter as practicable.
The Company hereby acknowledges that:
· Should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
· The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
· The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[Signature page follows]
Very truly yours,
LIFESCI ACQUISITION CORP.
Show Raw Text
CORRESP
1
filename1.htm
LifeSci Acquisition Corp.
250 W. 55th St., #3401
New York, New York 10019
March 5, 2020
VIA EDGAR & TELECOPY
Ronald Alper
Division of Corporation Finance
Office of Real Estate & Construction
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: LifeSci Acquisition Corp. (the “Company”)
Registration Statement on Form S-1
(File No. 333-236466) (the “Registration Statement”)
Dear Mr. Alper:
The Company hereby requests,
pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration
Statement so that such Registration Statement will become effective as of 4:00 p.m. on March 5, 2020, or as soon thereafter as
practicable.
The Company hereby acknowledges that:
· Should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority,
declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration
Statement;
· The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement
effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration
Statement; and
· The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.
[Signature page follows]
Very truly yours,
LIFESCI ACQUISITION CORP.
By:
/s/ Andrew McDonald
Name: Andrew McDonald
Title: Chief Executive Officer
Acceleration Request:
333-236466